Caricamento...
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
OBJECTIVE: Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety...
Salvato in:
| Pubblicato in: | Clin Psychopharmacol Neurosci |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean College of Neuropsychopharmacology
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383014/ https://ncbi.nlm.nih.gov/pubmed/32702221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.3.423 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|